Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,312 public trials 328 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

NCT01047501

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations
  • Amarin Investigational Site Muscle Shoals, Alabama, United States
  • Amarin Investigational Site Scottsboro, Alabama, United States
  • Amarin Investigational Site Phoenix, Arizona, United States
  • Amarin Investigational Site Tucson, Arizona, United States
View all 80 locations
View Trial Details
Completed

Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

NCT01047683

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations
  • Amarin Investigational Site Sacramento, California, United States
  • Amarin Investigational Site Golden, Colorado, United States
  • Amarin Investigational Site Miami, Florida, United States
  • Amarin Investigational Site Miami, Florida, United States
View all 60 locations
View Trial Details
Completed

A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

NCT01492361

Conditions
Acute Coronary Syndrome, Angina Pectoris, Arterial Occlusive Diseases, +18 more
Locations
  • Amarin Investigational Site Birmingham, Alabama, United States
  • Amarin Investigational Site Birmingham, Alabama, United States
  • Amarin Investigational Site Huntsville, Alabama, United States
  • Amarin Investigational Site Mobile, Alabama, United States
View all 410 locations
View Trial Details

Related conditions